@Article{Krynicka-Mazurek2012,
journal="Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery",
issn="1731-5530",
volume="9",
number="1",
year="2012",
title="NIEWYDOLNOŚĆ SERCA I PŁUC, TRANSPLANTOLOGIASuccessful use of cidofovir to treat refractory cytomegalovirus infection in heart transplant recipient – a case report",
abstract="Cytomegalovirus (CMV) infection poses a serious risk to patients after organ transplantation. It affects not only the early postoperative period, but through indirect effects contributes to shortening the long-term survival. CMV infection typically occurs within the period from the 2nd to the 6th month after organ transplantation. CMV infection that presents after 6 months is described as late CMV disease. Late onset CMV infection may present in an atypical way; therefore the diagnosis of CMV disease should be taken into consideration at any time after transplantation. In this article we present a clinical case of atypical CMV infection in a patient after orthotopic heart transplantation. It was unusual because of the timing and because of the lack of characteristic signs and symptoms. We also describe our experiences with cidofovir, a second-line antiviral drug, which is rarely used in patients after solid organ transplantation.",
author="Krynicka-Mazurek, Anna
and Zakliczyński, Michał
and Nożyński, Jerzy
and Przybylski, Roman
and Zembala, Marian",
pages="78--81",
url="https://www.termedia.pl/NIEWYDOLNOSC-SERCA-I-PLUC-TRANSPLANTOLOGIA-Successful-use-of-cidofovir-to-treat-refractory-cytomegalovirus-infection-in-heart-transplant-recipient-a-case-report,40,18417,1,1.html"
}